X4 Pharmaceuticals, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire X4 Pharmaceuticals, Inc.
Quantité totale PI 84
Rang # Quantité totale PI 16 202
Note d'activité PI 2,8/5.0    80
Rang # Activité PI 8 617
Symbole boursier XFOR (nasdaq)
ISIN US98420X1037
Capitalisation 90.00M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

25 8
6 4
29 5
7
 
Dernier brevet 2025 - Dual cxcr4-btk inhibitors
Premier brevet 2016 - Methods for treating cancer
Dernière marque 2025 - XOLREMDI
Première marque 2019 - X4 PHARMACEUTICALS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations for the treatment of WHIM syndrome; pharmaceutical preparations for ...
Invention Methods for treating neutropenia. The present invention relates to methods of treating patients w...
Invention Treatment of medical disorders using cxcr4 inhibitors. The present invention relates to methods o...
2024 P/S Pharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for t...
Invention Methods for treating immunodeficiency disease. The present invention relates to methods of treat...
Invention Compositions of cxcr4 inhibitors and methods of preparation and use. The present invention provi...
Invention Synthesis of mavorixafor and intermediates thereof. The present invention relates to methods for ...
P/S Providing news and information about medical research to patients and their caregivers in the fie...
2023 Invention Cxcr4 inhibitors for treatment of neurological diseases. The present invention provides CXCR4 inh...
Invention Cxcr4 inhibitors and uses thereof. The present invention provides compounds, compositions thereo...
Invention Combination therapies for treating hyperproliferative disorders. The present invention provides m...
Invention Treatments for conditions involving increased il-6 levels. Various inflammatory conditions result...
Invention Compositions of cxcr4 inhibitors and methods of preparation and use. The present invention provid...
Invention Dual cxcr4-btk inhibitors. The present invention relates to compounds and methods useful for dua...
Invention Dual cxcr4-btk inhibitors. The present invention relates to compounds and methods useful for dual...
Invention Treatments for single-mutant waldenström's macroglobulinemia. The present invention relates to me...
2022 Invention Methods for treating primary immunodeficiency. The present invention relates to methods of treat...
Invention Methods for treating primary immunodeficiency. The present invention relates to methods of treati...
Invention Synthesis of mavorixafor and intermediates thereof. The present invention relates to methods for...
Invention Cxcr4 inhibitors and uses thereof. The present invention provides compounds, compositions thereof...
P/S Pharmaceutical preparations for the treatment of cancers, blood disorders, neurological disorders...
P/S Pharmaceutical preparations for the treatment of cancers, rare diseases, primary immune disorder...
P/S Genetic testing for scientific research purposes. Providing information in the field of the treat...
P/S Genetic testing for scientific research purposes. Providing information in the field of the treat...
2021 P/S providing information in the field of the treatment of cancers, rare diseases, primary immune dis...
Invention Deuterated compounds and uses thereof. The present invention provides deuterium-enriched CXCR4 i...
Invention Cxcr4 inhibitors and uses thereof. The present invention relates to compounds and methods of inhi...
P/S Pharmaceutical preparations for human use.
2020 Invention Combination treatments for waldenstrom's macroglobulinemia. The present invention relates to met...
Invention Combination treatments for waldenstrom's macroglobulinemia. The present invention relates to meth...
Invention Methods for treating immunodeficiency disease. The present invention relates to methods of treati...
2019 P/S Pharmaceutical preparations for the treatment of cancers, rare diseases, primary immune disorders...
Invention Cancer serum biomarkers and methods of use thereof. The present invention relates, in part, to c...
Invention Cancer serum biomarkers and methods of use thereof. The present invention relates, in part, to ce...
2018 Invention Acyclic cxcr4 inhibitors and uses thereof. The present invention relates to compounds and method...
Invention Acyclic cxcr4 inhibitors and uses thereof. The present invention relates to compounds and methods...
Invention Cancer biomarkers and methods of use thereof. The present invention relates, in part, to certain...
Invention Cancer biomarkers and methods of use thereof. The present invention relates, in part, to certain ...
Invention Methods for treating cancer. The present invention relates to methods of treating cancer, in whi...
2017 Invention Methods for treating cancer. The present invention relates to methods of treating patients with a...
Invention Methods for treating cancer. The present invention relates to methods of treating patients with ...